Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy

Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy

Alzheimer's disease (AD), characterized by β-amyloid (Aβ) aggregation and neuroinflammation, remains a formidable clinical challenge. Herein, we present an innovative nose-to-brain delivery platform utilizing lactoferrin (Lf)-functionalized lipid nanoparticles (LNPs) co-encapsulating α-mangosti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanyan Xu, Xiangtong Ye, Yanfeng Du, Wenqin Yang, Fan Tong, Wei Li, Qianqian Huang, Yongke Chen, Hanmei Li, Huile Gao, Weiwei Zhang
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	Nose-to-brain delivery Lipid nanoparticle Alzheimer's disease β-Amyloid clearance α-Mangostin β-Site APP cleaving enzyme 1
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383525001182
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clearing Amyloid-Beta by Astrocytes: The Role of Rho GTPases Signaling Pathways as Potential Therapeutic Targets
by: Gyeongah Park, et al.
Published: (2024-12-01)

The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
by: Yuichi Kawai, et al.
Published: (2025-07-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Cross-sectional and longitudinal quantification of total white matter perivascular space volume fraction in Dutch-type Cerebral Amyloid Angiopathy
by: Manon R. Schipper, et al.
Published: (2025-01-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

The role of neuroinflammation in cerebral amyloid angiopathy
by: Hilde van den Brink, et al.
Published: (2024-12-01)

The Effect of Polyethylene Terephthalate Nanoplastics on Amyloid-β Peptide Fibrillation
by: Narmin Bashirova, et al.
Published: (2025-03-01)

The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies
by: Zahra Razmkhah, et al.
Published: (2024-10-01)

Identification and characterization of variants in PSEN1, PSEN2, and APP genes in Chinese patients with early-onset Alzheimer's disease
by: Haitian Nan, et al.
Published: (2025-02-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Targeting Soluble Amyloid Oligomers in Alzheimer’s Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration
by: Manuel Menendez-Gonzalez
Published: (2025-01-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01)

Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage
by: Philipp Arndt, et al.
Published: (2025-08-01)

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01)

A Bilingual Nanobiosensor for Cross‐Category Integrated Decoding of the Beta‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1–Aβ Oligomer Signaling Pathway
by: Tao Cheng, et al.
Published: (2024-11-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

New Tacrine Dimers Alleviate the Intracellular Amyloid-β-induced Cognitive Disturbance and Oxidative Stress in Mice
by: ANA ELISA GONÇALVES, et al.
Published: (2025-07-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

Stem cell therapy offers new hope for the treatment of Alzheimer’s disease
by: Guodong He, et al.
Published: (2025-08-01)

Amyloid β perturbs elevated heme flux induced with neuronal development
by: Chantal Vidal, et al.
Published: (2019-01-01)

In vitro degradation of β‐amyloid fibrils by microbial keratinase
by: Debananda S. Ningthoujam, et al.
Published: (2019-01-01)

The effects of traumatic brain Injury, post-traumatic stress disorder on Amyloid-β associated network hyperconnectivity and progression of gray matter atrophy
by: Susanne G. Mueller
Published: (2025-01-01)

Memory reconsolidation impairment by amyloid beta (1–42) and its prevention by non-competitive antagonists of NMDA receptors
by: A. A. Tiunova, et al.
Published: (2025-07-01)

Photoelectrochemical immunosensing of amyloid-β peptide using nanoplasmonic macroporous bismuth vanadate for Alzheimer's disease diagnosis
by: Wenting Chen, et al.
Published: (2025-06-01)

Distinct Chemical Determinants are Essential for Achieving Ligands for Superior Optical Detection of Specific Amyloid‐β Deposits in Alzheimer's Disease
by: Dr. Xiongyu Wu, et al.
Published: (2024-12-01)

Gentiacaulein inhibits glucose transport to induce PRKAA1-mediated autophagy to clear amyloid beta and associated inflammation in primary astrocytes
by: Ankita Sharma, et al.
Published: (2024-12-01)

Distribution of β-amyloid and pTau in brain cortex depending on age and mental state
by: Alexandra V. Sentyabreva, et al.
Published: (2024-12-01)

Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
by: Tsu-Kung Lin, et al.
Published: (2024-11-01)

Docosahexaenoic acid-acylated astaxanthin monoester enhances microglial autophagy for ameliorating amyloid-β load and cognitive deficits in models of Alzheimer’s disease
by: Xiaoxu Wang, et al.
Published: (2025-06-01)

The relationship between postoperative delirium and plasma amyloid beta oligomer
by: YoungSoon Yang, et al.
Published: (2025-04-01)

Efficient strategy for alleviating neuronal apoptosis and oxidative stress damage of Alzheimer's disease through dual targeting BCL-2 gene promoter i-motif and β-amyloid
by: Dongsheng Ji, et al.
Published: (2025-05-01)

Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease
by: Chenyu Zhuang, et al.
Published: (2025-03-01)

Amyloid-β-induced alteration of fast and localized calcium elevations in cultured astrocytes
by: Kaito Nakata, et al.
Published: (2025-05-01)

Antioxidant, anti-acetylcholinesterase, and anti-amyloid-β peptide aggregations of hispolon and its analogs in vitro and improved learning and memory functions in scopolamine-induced ICR mice
by: Chang-Hang Yang, et al.
Published: (2024-12-01)

Revealing the regulation of water dipole potential to aggregation of amyloid‐β 42 at chiral interface by surface‐enhanced infrared absorption spectroscopy
by: Manyu Zhu, et al.
Published: (2024-10-01)

A secondary analysis of cortical atrophy and plasma amyloid β patterns in older patients with cognitive frailty undergoing elective surgery
by: Rudolf Mörgeli, et al.
Published: (2025-07-01)

RETRACTED: NGF protects neuroblastoma cells against β‐amyloid‐induced apoptosis via the Nrf2/HO‐1 pathway
by: Rui Su, et al.
Published: (2019-12-01)